Cannabinoids Show Consistent Anti-Tumor Effects Across Brain and Breast Cancers, New Review Finds

A preclinical meta-analysis in Pharmaceuticals finds cannabis compounds exert consistent, statistically significant anti-tumor effects in glioblastoma and breast cancer models and may enhance chemotherapy efficacy; CBD shows the broadest anti-tumor profile with a favorable safety record, but THC effects are variable and not all combinations are beneficial, underscoring the need for rigorous preclinical screening before clinical translation.